RNA, 7SL, cytoplasmic 612, pseudogene (RN7SL612P)

RN7SL612P (RNA, 7SL, cytoplasmic 612, pseudogene) is a classified pseudogene, which means it is a genomic sequence derived from the ancestor of a functional gene but has lost the ability to encode a functional product through accumulation of mutations[1][5][6]. This pseudogene is related to the RNA, 7SL, which is a component of the signal recognition particle (SRP); however, RN7SL612P itself is not transcribed into a functional RNA and does not participate in known biological or disease processes, and is not recognized as a therapeutic target[1][5][6]. Pseudogenes like RN7SL612P are distinct from their functional paralogs and have no established protein or direct RNA product activity. The human genome contains several hundred dispersed 7SL RNA-like sequences, the overwhelming majority of which are nonfunctional pseudogenes produced by retrotransposition or related molecular events[5][6]. This entry is problematic for two reasons: - It is not a receptor, enzyme, transporter, or functional RNA—therefore not a therapeutic target[1][6]. - Its status as a pseudogene makes it functionally null, and it should not be used as a canonical target for drug discovery or disease biomarker purposes[5][6]. No information is available on drugs, mechanisms of action, biomarker status, biological functions, or disease relevance for RN7SL612P. If you require information about the functional SRP RNA gene (such as RN7SL1, which is part of the signal recognition particle), it is available and recognized with important biological and disease roles[3][4], but RN7SL612P is not functionally involved.

Other names

RN7SL612PRNA, 7SL, cytoplasmic 612 pseudogene